W S Aronow



  1. Yandrapalli S, Gupta S, Andries G, Cooper H, Aronow W. Drug Therapy of Dyslipidemia in the Elderly. Drugs Aging. 2019;36:321-340 pubmed publisher
    ..Future investigations of dyslipidemia therapies must appropriately include this at-risk population to identify optimal drugs and drug combinations that have a high benefit:risk ratio for the prevention of ASCVD in the elderly. ..
  2. request reprint
    Aronow W. Antiplatelet therapy in peripheral arterial disease. Curr Drug Targets Cardiovasc Haematol Disord. 2004;4:265-7 pubmed
    ..0028) reduction in vascular death, nonfatal myocardial infarction, and nonfatal stroke than patients randomized to aspirin 325 mg daily. These data favor the use of clopidogrel in patients with PAD. ..
  3. request reprint
    Aronow W. Use of antiplatelet drugs in the treatment of acute coronary syndromes. Cardiovasc Hematol Disord Drug Targets. 2013;13:151-7 pubmed
    ..Clinical trial data in patients with acute coronary syndromes do not support the use of intravenous cangrelor or oral voraxapar in the treatment of these patients. ..
  4. Harikrishnan P, Gupta T, Palaniswamy C, Kolte D, Khera S, Mujib M, et al. Complete Heart Block Complicating ST-Segment Elevation Myocardial Infarction: Temporal Trends and Association With In-Hospital Outcomes. JACC Clin Electrophysiol. 2015;1:529-538 pubmed publisher
    ..In patients with CHB complicating STEMI, there was no change in risk-adjusted in-hospital mortality during the study period. ..
  5. Gupta T, Harikrishnan P, Kolte D, Khera S, Subramanian K, Mujib M, et al. Trends in management and outcomes of ST-elevation myocardial infarction in patients with end-stage renal disease in the United States. Am J Cardiol. 2015;115:1033-41 pubmed publisher
  6. Aronow W. Current treatment of hypertension in patients with coronary artery disease recommended by different guidelines. Expert Opin Pharmacother. 2016;17:205-15 pubmed publisher
    ..The blood pressure should be < 140/90 mm Hg in patients aged < 80 years and the systolic blood pressure < 150 mm Hg if they are ≥ 80 years. ..
  7. Aronow W, Frishman W. Contemporary Drug Treatment of Hypertension: Focus on Recent Guidelines. Drugs. 2018;78:567-576 pubmed publisher
    ..The selection of antihypertensive drug treatment is discussed. ..
  8. Tariq S, Aronow W. Use of Inotropic Agents in Treatment of Systolic Heart Failure. Int J Mol Sci. 2015;16:29060-8 pubmed publisher
    ..Inotropes can help reduce frequency of hospitalizations and improve symptoms in these patients. ..
  9. Aronow W. Blood Pressure Goals and Targets in the Elderly. Curr Treat Options Cardiovasc Med. 2015;17:394 pubmed publisher

More Information


  1. Aronow W. Treating hypertension and prehypertension in older people: when, whom and how. Maturitas. 2015;80:31-6 pubmed publisher
    ..The choice of specific antihypertensive drugs such as diuretics, ACE inhibitors, ARBs, beta blockers, or calcium channel blockers depends on efficacy, tolerability, presence of specific comorbidities and cost. ..
  2. request reprint
    Aronow W. Valvular aortic stenosis in the elderly. Cardiol Rev. 2007;15:217-25 pubmed
    ..Patients with a bioprosthetic aortic valve without any of these 4 risk factors should be treated with aspirin 75-100 mg daily. ..
  3. request reprint
    Aronow W, Frishman W, Cheng Lai A. Cardiovascular drug therapy in the elderly. Cardiol Rev. 2007;15:195-215 pubmed
    ..This article also discusses the adverse effects of cardiovascular drugs in the elderly, medications best to avoid in the elderly, and the prudent use of medications in the elderly. ..
  4. Gupta T, Harikrishnan P, Kolte D, Khera S, Aronow W, Mujib M, et al. Outcomes of acute myocardial infarction in patients with hypertrophic cardiomyopathy. Am J Med. 2015;128:879-887.e1 pubmed publisher
    ..Compared with patients without hypertrophic cardiomyopathy, patients with hypertrophic cardiomyopathy with ST-elevation myocardial infarction have lower risk-adjusted in-hospital mortality. ..
  5. Aronow W. Office management of hypertension in older persons. Am J Med. 2011;124:498-500 pubmed publisher
    ..If the blood pressure is more than 20/10 mm Hg above the goal blood pressure, drug therapy should be initiated with 2 antihypertensive drugs. Other coronary risk factors must be treated. ..
  6. request reprint
    Aronow W. Drug treatment of peripheral arterial disease in the elderly. Drugs Aging. 2006;23:1-12 pubmed
    ..In addition, medical therapy may result in significant improvements in walking ability that may obviate the need for lower extremity angioplasty with stenting and bypass surgery. ..
  7. Gupta T, Kolte D, Khera S, Harikrishnan P, Mujib M, Aronow W, et al. Smoker's Paradox in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. J Am Heart Assoc. 2016;5: pubmed publisher
  8. Gupta T, Kolte D, Mohananey D, Khera S, Goel K, Mondal P, et al. Relation of Obesity to Survival After In-Hospital Cardiac Arrest. Am J Cardiol. 2016;118:662-7 pubmed publisher
    ..In conclusion, this large retrospective analysis of a nationwide cohort of patients with IHCA demonstrated higher risk-adjusted odds of survival in obese patients, consistent with an "obesity paradox." ..
  9. Aronow W. Treatment of Heart Failure with Abnormal Left Ventricular Systolic Function in Older Adults. Heart Fail Clin. 2017;13:467-483 pubmed publisher
    ..Exercise training is recommended. Indications for implantable cardioverter-defibrillator and cardiac resynchronization therapy are discussed. ..
  10. Aronow W. Heart Failure Complicating Acute Mtyocardial Infarction. Heart Fail Clin. 2017;13:513-525 pubmed publisher
  11. Dooley D, Lam P, Ahmed A, Aronow W. The Role of Positive Inotropic Drugs in the Treatment of Older Adults with Heart Failure and Reduced Ejection Fraction. Heart Fail Clin. 2017;13:527-534 pubmed publisher
    ..However, recommendations from national heart failure guidelines may be generalized to older HFrEF patients on an individual basis, taking into consideration the basic geriatric principles of pharmacotherapy: start low and go slow. ..
  12. Jacobson J, Iwai S, Aronow W. Treatment of Ventricular Arrhythmias and Use of Implantable Cardioverter-Defibrillators to Improve Survival in Older Adult Patients with Cardiac Disease. Heart Fail Clin. 2017;13:589-605 pubmed publisher
    ..The value of implantable cardiac defibrillators (ICDs) may be influenced by patient age. This article discusses long-term treatment of VA and the use of ICDs in the elderly. ..
  13. request reprint
    Aronow W. Management of peripheral arterial disease. Cardiol Rev. 2005;13:61-8 pubmed
    ..However, amputation should be performed if tissue loss has progressed beyond the point of salvage, if surgery is too risky, if life expectancy is very low, or if functional limitations diminish the benefit of limb salvage. ..
  14. Rochlani Y, Khan M, Aronow W. Managing Hypertension in Patients Aged 75 Years and Older. Curr Hypertens Rep. 2017;19:88 pubmed publisher
    ..The initial drug of choice for the treatment of hypertension in adults aged 75 years and older should be based on co-morbidities, co-incidental indications, tolerability, and cost. ..
  15. Aronow W. Managing Hypertension in the Elderly: What is Different, What is the Same?. Curr Hypertens Rep. 2017;19:67 pubmed publisher
    ..The incidence of serious adverse events was similar in both treatment groups. The SPRINT trial provides very important information on the efficacy and safety of lowering the SBP to <120 mmHg in elderly adults with hypertension. ..
  16. Aronow W. Office management of peripheral arterial disease. Am J Med. 2010;123:790-2 pubmed publisher
  17. Palaniswamy C, Frishman W, Aronow W. Carcinoid heart disease. Cardiol Rev. 2012;20:167-76 pubmed publisher